Becker Postdoc Dr Amanda Ridley from the Dyer lab is the recipient of the 2024 ICIS-Pfizer Amanda Proudfoot Tribute Award for Advances in Chemokine Biology by a Trainee.

Amanda’s research in the Dyer lab focuses on defining how chemokines and glycosaminoglycan (GAG) sugars on endothelial proteoglycans work together to facilitate leukocyte recruitment. She has demonstrated that chemokine localisation and availability is regulated by chemokines and their differential interactions with GAGs. Further, she was part of the team that identified that the chemokine CXCL4 drives widespread immune cell recruitment by interacting with extracellular matrix proteoglycans. 

Amanda also secured £20,000 worth of funding to support her next steps of writing independent fellowship applications to pursue her career as a chemokine biologist.

Image: ICIS

Related